Jyothy Labs (532926) Q4 23/24 earnings summary

Executive summary

• FY24 consolidated revenue grew 10.9% to ₹2,756.9 crore; sales value growth was 10.9% and volume growth 9.0%, with minor portfolio price cuts.

• Operating EBITDA margin expanded to 17.4% from 12.7%; PAT rose 54% to ₹369.3 crore, amid inflation, subdued rural demand and intense competition.

• Market share improved across key categories; direct distribution reached 1.2 million outlets and products were available in 2.8 million outlets.

Financial highlights

• Consolidated revenue from operations was ₹2,756.9 crore versus ₹2,486.0 crore in FY23; net sales value growth was 10.9%.

• Operating EBITDA was ₹479.8 crore versus ₹315.9 crore, up 51.9%; margin rose to 17.4% from 12.7%.

• PAT was ₹369.3 crore versus ₹239.7 crore, up 54%; PBT before exceptional items was ₹478.8 crore versus ₹292.2 crore.

• COGS fell 2.2% to ₹1,403.8 crore on lower raw and packaging material prices; A&P spend rose 30.9% to ₹228.2 crore, or 8.3% of net sales.

• Operating cash flow was ₹457.9 crore; cash and bank balances, including investments, reached ₹618 crore at year-end.

Outlook and guidance

• Strategic priorities include volume-led growth, rural reach expansion, continued investment in brands and distribution, and manufacturing capacity augmentation.

• Digital and ESG investment, product innovation and prudent capital allocation are intended to support scale and long-term growth.

• FY25 FMCG growth is expected to be volume-led, supported by stable prices, favourable monsoon expectations and improving rural sentiment; this is industry outlook, not company-specific guidance.